Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Randomized Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Sudan Ebolavirus Vaccines in Uganda

NCT05909358 is registered in ClinicalTrials.gov with Makerere University as lead sponsor.

NCT NCT05909358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05909358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Randomized Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Sudan Ebolavirus Vaccines in Uganda
Lead sponsor
Makerere University
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
July 31, 2023
Completion date
September 30, 2027
Enrollment
2,121 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sudan ebola virus vaccines